Dexamethasone Patent Expiration

Dexamethasone is Used for treating eye conditions such as diabetic macular edema, macular edema, non-infectious uveitis, and uveitis by delivering an ocular implant. It was first introduced by Merck And Co Inc in its drug Decadron on Approved Prior to Jan 1, 1982. Other drugs containing Dexamethasone are Decaderm, Maxidex, Dexycu Kit, Dextenza, Hemady, Hexadrol, Decaspray, Ozurdex. 37 different companies have introduced drugs containing Dexamethasone.


Dexamethasone Patents

Given below is the list of patents protecting Dexamethasone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Dexycu Kit US11097061 Systems, kits and methods for loading and delivering a small volume dose from a syringe Jun 23, 2039 Eyepoint Pharms
Hemady US10537585 Compositions comprising dexamethasone Dec 18, 2037 Dexcel
Hemady US11304961 Compositions comprising dexamethasone Dec 18, 2037 Dexcel
Dextenza US11458041 Punctal plug and bioadhesives Nov 16, 2037 Ocular Therapeutix
Dexycu Kit US10022502 Dose guides for injection syringe Jun 22, 2034 Eyepoint Pharms
Dexycu Kit US10028965 Use of sustained release dexamethasone in post-cataract surgery inflammation May 23, 2034 Eyepoint Pharms
Dexycu Kit US10159683 Use of sustained release dexamethasone in post-cataract surgery inflammation May 23, 2034 Eyepoint Pharms
Dexycu Kit US10799642 Dose guides for injection syringe May 11, 2032 Eyepoint Pharms
Dextenza US8409606 Drug delivery through hydrogel plugs May 14, 2030 Ocular Therapeutix
Dextenza US8563027 Drug delivery through hydrogel plugs Feb 12, 2030 Ocular Therapeutix
Dextenza US9254267 Composite hydrogel drug delivery systems Sep 11, 2024

(Expired)

Ocular Therapeutix
Ozurdex US6899717 Methods and apparatus for delivery of ocular implants Nov 01, 2023

(Expired)

Abbvie
Dexycu Kit US6960346 Vehicles for delivery of biologically active substances Jul 03, 2023

(Expired)

Eyepoint Pharms
Ozurdex US10076526 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US10702539 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US8034366 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US8034370 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US8506987 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Ozurdex US9192511 Ocular implant made by a double extrusion process Jan 09, 2023

(Expired)

Abbvie
Dexycu Kit US7560120 Vehicles for delivery of biologically active substances Sep 05, 2022

(Expired)

Eyepoint Pharms
Ozurdex US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use Nov 28, 2021

(Expired)

Abbvie
Ozurdex US6726918 Methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie
Ozurdex US7033605 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US8043628 Methods for reducing edema Oct 20, 2020

(Expired)

Abbvie
Ozurdex US8063031 Implants and methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie
Ozurdex US8088407 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9012437 Implants and methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9283178 Methods for treating edema in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9592242 Methods for treating edema in the eye and intraocular implants for use therefor Oct 20, 2020

(Expired)

Abbvie
Ozurdex US9775849 Implants and methods for treating inflammation-mediated conditions of the eye Oct 20, 2020

(Expired)

Abbvie



Dexamethasone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Dexamethasone Generic API Manufacturers

Several generic applications have been filed for Dexamethasone. The first generic version for Dexamethasone was by Watson Laboratories Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Corepharma Llc and was approved on Sep 17, 2024.

Given below is the list of companies who have filed for Dexamethasone generic, along with the locations of their manufacturing plants worldwide.


1. ALLERGAN HERBERT

Allergan Herbert Div Allergan Inc has filed for 1 generic for Dexamethasone. This 0.01% **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name AEROSEB-DEX. Given below are the details of the strengths of this generic introduced by Allergan Herbert.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

aerosol Discontinued TOPICAL N/A Approved Prior to Jan 1, 1982





2. ALPHARMA US PHARMS

Alpharma Us Pharmaceuticals Division has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Alpharma Us Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG/5ML

elixir Discontinued ORAL N/A Oct 10, 1986





3. ALVOGEN

Alvogen Inc has filed for 4 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Prescription ORAL BP Apr 28, 1983
0.75MG

tablet Prescription ORAL BP Apr 28, 1983
4MG

tablet Prescription ORAL AB Apr 28, 1983
6MG

tablet Prescription ORAL AB Nov 28, 1983


Manufacturing Plant Locations
New

Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.

Country City Firm Name
United States
Morristown Alvogen, Inc





4. AMNEAL

Amneal Eu Ltd has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6MG

tablet Prescription ORAL AB Oct 14, 2021
4MG

tablet Prescription ORAL AB Oct 14, 2021
2MG

tablet Prescription ORAL AB Sep 8, 2022


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Paterson Amneal Pharmaceuticals, Llc
East Hanover Amneal Pharmaceuticals LLC
Glasgow Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
Branchburg Amneal Pharmaceuticals, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Piscataway Amneal Pharmaceuticals, LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
India
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Hyderabad Amneal Oncology Private Limited
Matoda Amneal Pharmaceuticals Private Ltd.





5. APOTEX

Apotex Inc has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AB Aug 23, 2023
1.5MG

tablet Prescription ORAL AB Aug 23, 2023
1MG

tablet Prescription ORAL AB Aug 23, 2023
0.75MG

tablet Prescription ORAL AB Aug 23, 2023
6MG

tablet Prescription ORAL AB Aug 23, 2023
4MG

tablet Prescription ORAL AB Aug 23, 2023
0.5MG

tablet Prescription ORAL AB Aug 23, 2023


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Toronto Apotex Inc.
Brantford Apotex Pharmachem Inc.
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
India
Bangalore Apotex Pharmachem India Pvt Ltd.
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited





6. BAUSCH

Bausch Health Americas Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Bausch.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Discontinued ORAL N/A Aug 15, 2008


Manufacturing Plant Locations
New

Bausch's manufacturing plants are situated in 2 countries - United States, Canada. Given below are the details of these plant locations as well as the firm names of Bausch as present at those locations.

Country City Firm Name
United States
Rancho Cucamonga Bausch and Lomb, Incorporated
Bridgewater Bausch Health Companies, Inc.
Greenville Bausch & Lomb Incorporated
Irvine Bausch and Lomb, Incorporated
Rochester Bausch Health Americas, Inc.
Petaluma Bausch Health Americas, Inc.
Woodruff Bausch & Lomb Inc
Rochester Bausch & Lomb Incorporated
Saint Louis Bausch & Lomb Inc
Lancaster Bausch & Lomb Incorporated
Wilmington Bausch & Lomb Incorporated
Manchester Bausch & Lomb, Inc.
Bridgewater Bausch and Lomb, Inc
Canada
Laval Bausch Health Companies Inc.
Steinbach Bausch Health Companies Inc.





7. BIONPHARMA

Bionpharma Inc has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4MG

tablet Prescription ORAL AB Apr 19, 2023
6MG

tablet Prescription ORAL AB Apr 19, 2023
2MG

tablet Prescription ORAL AB Apr 26, 2023


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





8. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG/5ML

elixir Prescription ORAL AA May 11, 2011





9. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982





10. COREPHARMA

Corepharma Llc has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Prescription ORAL AB Sep 17, 2024
6MG

tablet Prescription ORAL AB Sep 17, 2024
4MG

tablet Prescription ORAL AB Sep 17, 2024
0.5MG

tablet Prescription ORAL AB Sep 17, 2024
2MG

tablet Prescription ORAL AB Sep 17, 2024
0.75MG

tablet Prescription ORAL AB Sep 17, 2024
1MG

tablet Prescription ORAL AB Sep 17, 2024


Manufacturing Plant Locations
New

Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.

Country City Firm Name
United States
Middlesex CorePharma, LLC





11. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 9 different strengths of generic version for Dexamethasone. Out of these 1mg/ml version comes by the name DEXAMETHASONE INTENSOL. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Prescription ORAL AB Approved Prior to Jan 1, 1982
0.5MG

tablet Prescription ORAL AB Approved Prior to Jan 1, 1982
4MG

tablet Prescription ORAL AB Approved Prior to Jan 1, 1982
0.75MG

tablet Prescription ORAL AB Approved Prior to Jan 1, 1982
2MG

(reference standard)

tablet Prescription ORAL AB Aug 26, 1982
0.5MG/5ML

(reference standard)

solution Prescription ORAL N/A Sep 1, 1983
1MG/ML

(reference standard)

concentrate Prescription ORAL N/A Sep 1, 1983
1MG

(reference standard)

tablet Prescription ORAL AB Sep 15, 1983
6MG

(reference standard)

tablet Prescription ORAL AB Sep 15, 1983


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





12. IMPAX LABS

Impax Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982





13. KANCHAN HLTHCARE

Kanchan Healthcare Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Kanchan Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG/5ML

(reference standard)

elixir Prescription ORAL AA Approved Prior to Jan 1, 1982





14. KEY THERAP

Key Therapeutics Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Key Therap.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Discontinued ORAL N/A Apr 28, 1983





15. LARKEN LABS INC

Larken Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Larken Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Prescription ORAL AB Jul 17, 2017





16. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 6 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Prescription ORAL AB Aug 8, 2022
4MG

tablet Prescription ORAL AB Aug 8, 2022
6MG

tablet Prescription ORAL AB Aug 8, 2022
2MG

tablet Prescription ORAL AB May 9, 2023
0.75MG

tablet Prescription ORAL AB Oct 5, 2023
0.5MG

tablet Prescription ORAL AB Oct 5, 2023


Manufacturing Plant Locations
New

Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.

Country City Firm Name
United States
East Windsor Novitium Pharma LLC





17. PANGEA

Pangea Pharmaceuticals Llc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pangea.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG

tablet Discontinued ORAL N/A Apr 28, 1983


Manufacturing Plant Locations
New

Pangea's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Pangea as present at those locations.

Country City Firm Name
United States
Rockville Pangea Vegan Products Inc
Boca Raton PANGEA GROWERS GROUP LLC
Boston Pangea Shellfish and Seafood Company, Inc.
Seattle Pangea, LLC.





18. PAR PHARM

Par Pharmaceutical Inc has filed for 3 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Par Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG

tablet Prescription ORAL BP Apr 28, 1983
0.75MG

tablet Prescription ORAL BP Apr 28, 1983
4MG

tablet Prescription ORAL BP Apr 28, 1983


Manufacturing Plant Locations
New

Par Pharm's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Par Pharm as present at those locations.

Country City Firm Name
United States
Stratford Par Pharmaceutical Inc.
Hauppauge Par Pharmaceuticals





19. PHARMOBEDIENT CNSLTG

Pharmobedient Consulting has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG/5ML

elixir Discontinued ORAL N/A Jul 27, 1983





20. PHOENIX LABS NY

Phoenix Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Phoenix Labs Ny.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982





21. PRASCO

Prasco Llc Dba Prasco Laboratories has filed for 2 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Prasco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
4MG

tablet Prescription ORAL AB Apr 20, 2022


Manufacturing Plant Locations
New

Prasco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Prasco as present at those locations.

Country City Firm Name
United States
Mason Prasco LLC





22. PVT FORM

Private Formulations Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Pvt Form.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982





23. RISING

Rising Pharma Holdings Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG/5ML

elixir Prescription ORAL AA Jul 12, 2011


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Phoenix Rising Sun Farms Inc
Fort Bragg Rising Tide Sea Vegetables
Saddle Brook Rising Pharmaceuticals, Inc.
Decatur Rising Pharma Holdings, Inc
Livingston Risingsun Iodine Products Corp.
East Brunswick Rising Pharma Holding, Inc.
Mount Morris Rising Creek Bakery LLC
Rising Sun Rising Sun Veterinary Clinic
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





24. ROXANE

Roxane Laboratories Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982





25. SOLVAY

Solvay Pharmaceuticals has filed for 4 different strengths of generic version for Dexamethasone. Out of these 1.5mg version comes by the name DEXONE 1.5, 0.5mg version comes by the name DEXONE 0.5, 4mg version comes by the name DEXONE 4, 0.75mg version comes by the name DEXONE 0.75. Given below are the details of the strengths of this generic introduced by Solvay.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
4MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Solvay's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Solvay as present at those locations.

Country City Firm Name
United States
Willow Island Solvay, Inc
Spartanburg Solvay USA Inc
Longview Solvay Chemicals Inc
Chicago Heights Solvay USA Inc.





26. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
1.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982





27. UPSHER SMITH

Upsher Smith Laboratories Inc has filed for 2 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Upsher Smith.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982


Manufacturing Plant Locations
New

Upsher Smith's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Upsher Smith as present at those locations.

Country City Firm Name
United States
Maple Grove Upsher Smith Laboratories, LLC





28. WATSON LABS

Watson Laboratories Inc has filed for 5 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.25MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.5MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982
0.1%

suspension/drops Discontinued OPHTHALMIC N/A May 9, 1989





29. WHITEWORTH TOWN PLSN

Whiteworth Towne Paulsen Inc has filed for 1 generic for Dexamethasone. Given below are the details of the strengths of this generic introduced by Whiteworth Town Plsn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.75MG

tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982





30. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 7 different strengths of generic version for Dexamethasone. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2MG

tablet Prescription ORAL AB Feb 7, 2024
6MG

tablet Prescription ORAL AB Feb 7, 2024
4MG

tablet Prescription ORAL AB Feb 7, 2024
1.5MG

tablet Prescription ORAL AB Feb 7, 2024
0.75MG

tablet Prescription ORAL AB Feb 7, 2024
0.5MG

tablet Prescription ORAL AB Feb 7, 2024
1MG

tablet Prescription ORAL AB May 9, 2024


Manufacturing Plant Locations
New

Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.

Country City Firm Name
India
Jarod Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
Dabhasa Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Thane Zydus Lifesciences Limited
Matoda Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Ankleshwar Zydus Lifesciences Limited





Dexamethasone News

GSK promotes new success with Blenrep combination following withdrawal, while analysts predict significant growth.

07 Mar, 2024

See More